Faiz - Anwer

  • 215 Citations
  • 8 h-Index
20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Faiz - Anwer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Transplants Medicine & Life Sciences
Cell Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: A case report with literature review

Durer, S., Durer, C., Shafqat, M., Comba, I. Y., Malik, S., Faridi, W., Aslam, S., Ijaz, A., Tariq, M. J., Fraz, M. A., Usman, M., Khan, A. Y., McBride, A. & Anwer, F. ., Apr 1 2019, In : Immunotherapy. 11, 5, p. 373-378 6 p.

Research output: Contribution to journalReview article

Leukemia
Lymphocytes
Phenotype
Whole-Body Irradiation
Hematopoietic Stem Cell Transplantation

Denosumab vs Zoledronic Acid for Bone-Targeted Therapy in Multiple Myeloma: What Are the Unanswered Questions?

Chakraborty, R., Majhail, N. S. & Anwer, F. ., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalComment/debate

Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple Myeloma

Anwer, F. ., Gee, K. M., Iftikhar, A., Baig, M., Russ, A. D., Saeed, S., Zar, M. A., Razzaq, F., Carew, J., Nawrocki, S., Al-Kateb, H., Cavalcante Parr, N. N., McBride, A., Valent, J. & Samaras, C., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalReview article

Multiple Myeloma
Mutation
Histone Deacetylase Inhibitors
Cyclin D1
Multiple Drug Resistance

Pomalidomide-Based Regimens for Treatment of Relapsed and Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-analysis of Phase 2 and 3 Clinical Trials

Mushtaq, A., Iftikhar, A., Hassan, H., Lakhani, M., Sagar, F. N. U., Kamal, A., Zahid, U., Ali, Z., Razzaq, F., Zar, M. A., Hassan, S. F., Safdar, A., Raychaudhuri, S. & Anwer, F. ., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Phase III Clinical Trials
Multiple Myeloma
Meta-Analysis
Dexamethasone
pomalidomide
1 Citation (Scopus)

Rational cotargeting of HDAC6 and BET proteins yields synergistic antimyeloma activity

Carew, J. S., Espitia, C. M., Zhao, W., Visconte, V., Anwer, F. ., Kelly, K. R. & Nawrocki, S. T., Jan 1 2019, In : Blood Advances. 3, 8, p. 1318-1329 12 p.

Research output: Contribution to journalArticle

Open Access
Histone Deacetylases
Multiple Myeloma
Proteins
Apoptosis
Histone Deacetylase Inhibitors